Patents by Inventor Juan Hancke

Juan Hancke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10786522
    Abstract: The compositions described herein and featured in the present invention include those that comprise anthocyanidin combinations rich in delphinidins, including delphinidins such as the ones found in berries. The compositions can optionally include either compositions that comprise andrographolides, such as the ones found in a plant of the genus Andrographis, or compositions that comprise combinations of myrtillin, quercetin, or caffeoyl quinic derivatives and proanthocyanidins, such as the ones found in the herba of a plant of the genus Vaccinium.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: September 29, 2020
    Assignee: Maqui NewLife S.A.
    Inventors: Rafael Burgos, Juan Hancke, Evelyn Jara, Maria Hidalgo
  • Publication number: 20190151342
    Abstract: The compositions described herein and featured in the present invention include those that comprise anthocyanidin combinations rich in delphinidins, including delphinidins such as the ones found in berries. The compositions can optionally include either compositions that comprise andrographolides, such as the ones found in a plant of the genus Andrographis, or compositions that comprise combinations of myrtillin, quercetin, or caffeoyl quinic derivatives and proanthocyanidins, such as the ones found in the herba of a plant of the genus Vaccinium.
    Type: Application
    Filed: January 24, 2019
    Publication date: May 23, 2019
    Applicant: MAQUI NEW LIFE S.A.
    Inventors: Rafael Burgos, Juan Hancke, Evelyn Jara, Maria Hidalgo
  • Publication number: 20150164932
    Abstract: The compositions described herein and featured in the present invention include those that comprise anthocyanidin combinations rich in delphinidins, including delphinidins such as the ones found in berries. The compositions can optionally include either compositions that comprise andrographolides, such as the ones found in a plant of the genus Andrographis, or compositions that comprise combinations of myrtillin, quercetin, or caffeoyl quinic derivatives and proanthocyanidins, such as the ones found in the herba of a plant of the genus Vaccinium.
    Type: Application
    Filed: December 31, 2014
    Publication date: June 18, 2015
    Applicant: Maqui New Life SA
    Inventors: Rafael BURGOS, Juan HANCKE, Evelyn JARA, Maria HIDALGO
  • Publication number: 20140271573
    Abstract: A method of treating a muscular dystrophy disease in a patient includes administering an effective amount of a botanical drug isolated from Andrographis paniculata in combination with cell therapy. The method improves skeletal muscle performance.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE
    Inventors: Enrique Brandan, Daniel Cabrera, Jaime GUTIERREZ, Gabriela Morales, Claudio CABELLO-VERRUGIO, Juan Hancke
  • Publication number: 20110268825
    Abstract: The compositions described herein and featured in the present invention include those that comprise anthocyanidin combinations rich in delphinidins, including delphinidins such as the ones found in berries. The compositions can optionally include either compositions that comprise andrographolides, such as the ones found in a plant of the genus Andrographis, or compositions that comprise combinations of myrtillin, quercetin, or caffeoyl quinic derivatives and proanthocyanidins, such as the ones found in the herba of a plant of the genus Vaccinium.
    Type: Application
    Filed: March 30, 2011
    Publication date: November 3, 2011
    Inventors: Rafael Burgos, Juan Hancke, Evelyn Jara, Maria Hidalgo
  • Publication number: 20060063831
    Abstract: The diterpenic labdane 3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,ha-dimethyl-2-methylene-1-naphthalenyl]ethylidene]-dihydro-4-hydroxy-2(3h)-furanone, chemically diagrammed as inhibits the synthesis of pro-inflammatory cytokines, activates the PPAR-gamma receptor and diminishes nuclear factor kappa B. The compound is useful to treat auto-immune diseases, for organ and tissue transplantation, and to treat immunodeficiency (e.g., AIDS).
    Type: Application
    Filed: May 21, 2004
    Publication date: March 23, 2006
    Applicant: Hebal Powers Corporation
    Inventors: Juan Hancke Orozco, Rafael Burgos Aguilera